Home Newsfeeds Vertical Research Downgrades Univar Solns to Hold

Vertical Research Downgrades Univar Solns to Hold

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

byBenzinga Newsdesk

March 14, 2023

1 minute read

Vertical Research analyst Kevin McCarthy downgrades Univar Solns (NYSE:UNVR) from Buy to Hold.

Gladstone Commercial Still A Buy, But Analyst Lowers Expectations Due To Occupancy Slump

By Nabaparna Bhattacharya

May 5, 1:06 PM

EF Hutton analyst Gaurav Mehta reiterated a Buy rating on the shares of Gladstone Commercial Corp. (NASDAQ:GOOD), lowering the price target to…

GOOD

RBC Capital Maintains Outperform on Medtronic, Lowers Price Target to $102

By Benzinga Newsdesk

November 23, 9:49 AM

RBC Capital analyst Shagun Singh maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $110 to $102.

MDT

If You Invested $1,000 In Tesla When Joe Biden Was Elected President, Here’s How Much You’d Have Now

By Henry Khederian

March 3, 11:31 AM

The election of Joe Biden as U.S. president has been seen as a milestone in history for EV and clean energy manufacturing companies at large.

TSLA

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

April 11, 6:14 AM

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

ACOR

Vertical Research Downgrades Univar Solns to Hold

Related Posts

Gladstone Commercial Still A Buy, But Analyst Lowers Expectations Due To Occupancy Slump

RBC Capital Maintains Outperform on Medtronic, Lowers Price Target to $102

If You Invested $1,000 In Tesla When Joe Biden Was Elected President, Here’s How Much You’d Have Now

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket